Drug intelligence / Profile preview

nalbuphine + Long dan xie gan tang

Development stage
Unknown
Lead developer
Tri-Service General Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

nalbuphine + Long dan xie gan tang is a drug-herb combination investigated for potential pharmacokinetic and pharmacodynamic interactions. Nalbuphine is a semi-synthetic opioid analgesic that functions as a kappa-opioid receptor agonist and a mu-opioid receptor antagonist. Long dan xie gan tang (LDXGT), also known as Gentiana Decoction to Drain the Liver, is a traditional Chinese herbal formula typically used to treat conditions associated with damp-heat in the liver and gallbladder. The Tri-Service General Hospital conducted Phase 1 clinical research to evaluate how the co-administration of LDXGT affects the safety, metabolism, and efficacy of nalbuphine in healthy subjects. This study specifically aimed to identify herb-drug interactions that might alter the clinical profile of the opioid analgesic when used alongside traditional herbal medicine.

Brand names
Nubian
Other names
Nalbuphine with Long dan xie gan tangNubian with Long dan xie gan tangnalbuphine + Long dan xie gan tang-Tri-Service General Hospital
02

Targets

KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on nalbuphine + Long dan xie gan tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nalbuphine + Long dan xie gan tang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call